Showing results (21-30 of 527) with videos related to

Sort By:
Pageof 53
Therapeutic Advances in Drug Safety|June 18, 2019
Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic reviewJodie Belinda Hillen, Natalie Soulsby, Chris Alderman, et al.
Therapeutic Advances in Drug Safety|June 22, 2019
Variability in the clinical management of iron deficiency anaemia in older adults: results from a survey of UK specialists in the care of older peopleAlison I C Donaldson, Roy L Soiza, Katherine J Hands, et al.
Therapeutic Advances in Drug Safety|June 28, 2019
Frequency of undocumented medication discrepancies in discharge letters after hospitalization of older patients: a clinical record review studyTrine Graabæk, Babette Gorm Terkildsen, Kira Emilie Lauritsen, et al.
Therapeutic Advances in Drug Safety|July 2, 2019
Understanding adverse drug-related emergency department visits: development of a conceptual model through a systematic reviewAbubakar Ibrahim Jatau, Zayyanu Shitu, Garba Mohammed Khalid, et al.
Therapeutic Advances in Drug Safety|September 6, 2018
Medication use and potentially inappropriate prescribing in older adults with intellectual disabilities: a neglected area of researchMaire O'Dwyer, Philip McCallion, Mary McCarron, et al.
Therapeutic Advances in Drug Safety|April 7, 2018
Spontaneously reported adverse drug events related to tapentadol and oxycodone/naloxone in AustraliaCarmen Abeyaratne, Samanta Lalic, J Simon Bell, et al.
Therapeutic Advances in Drug Safety|April 26, 2019
Influence of pharmacist intervention on drug safety of geriatric inpatients: a prospective, controlled trialAngela Nachtigall, Hans J Heppner, Petra A Thürmann
Therapeutic Advances in Drug Safety|December 2, 2016
Rifampicin and isoniazid plasma concentrations in relation to adverse reactions in tuberculosis patients: a retrospective analysisL Aït Moussa, O El Bouazzi, S Serragui, et al.
Therapeutic Advances in Drug Safety|August 13, 2020
Esketamine: new hope for the treatment of treatment-resistant depression? A narrative reviewMohammed S Salahudeen, Cameron M Wright, Gregory M Peterson
Therapeutic Advances in Drug Safety|June 27, 2020
An overview of prevalence, determinants and health outcomes of polypharmacyMina Khezrian, Chris J McNeil, Alison D Murray, et al.
Pageof 53